This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval to change the location of the manufacturing facility of the ascites fluid used in the preparation of the monoclonal antibodies from the tosoh tokyo research center in ayase, japan to nisseiken, co. Ltd. In tokyo, japan.
| Device | AIA-PACK PA |
| Classification Name | Prostate-specific Antigen (psa) For Management Of Prostate Cancers |
| Generic Name | Prostate-specific Antigen (psa) For Management Of Prostate Cancers |
| Applicant | TOSOH BIOSCIENCE, INC. |
| Date Received | 2002-01-09 |
| Decision Date | 2002-09-09 |
| PMA | P910065 |
| Supplement | S003 |
| Product Code | LTJ |
| Advisory Committee | Immunology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Location Change - Manufacturer/sterilizer/packager/supplier |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | TOSOH BIOSCIENCE, INC. 6000 Shoreline Court suite 101 south San Francisco, CA 94080 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P910065 | Original Filing | |
| S009 | 2019-05-20 | Special (immediate Track) |
| S008 | 2011-03-30 | Normal 180 Day Track |
| S007 | 2009-04-24 | Normal 180 Day Track |
| S006 | 2005-06-06 | Normal 180 Day Track |
| S005 | 2004-04-07 | Normal 180 Day Track |
| S004 | 2003-06-04 | Normal 180 Day Track |
| S003 | 2002-01-09 | Normal 180 Day Track |
| S002 | 1999-12-16 | Normal 180 Day Track |
| S001 | 1999-03-25 | Panel Track |